CAS: 308242-62-8 - Remimazolam
Formula:C21H19BrN4O2
InChI:InChI=1S/C21H19BrN4O2/c1-13-12-24-21-17(7-9-19(27)28-2)25-20(16-5-3-4-10-23-16)15-11-14(22)6-8-18(15)26(13)21/h3-6,8,10-12,17H,7,9H2,1-2H3/t17-/m0/s1
InChI key:InChIKey=CYHWMBVXXDIZNZ-KRWDZBQOSA-N
SMILES:O=C(OC)CCC1N=C(C=2N=CC=CC2)C=3C=C(Br)C=CC3N4C1=NC=C4C
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Remimazolam REF: TR-R143600CAS: 308242-62-8 | - - - | 244.00 €~1,658.00 € | Fri 27 Dec 24 |
 | Remimazolam REF: 3D-FR181797CAS: 308242-62-8 | Min. 95% | To inquire | Mon 23 Dec 24 |
| Methyl 3-(8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo(1,2-A)(1,4)benzodiazepin-4-yl)propanoate REF: 3D-IMA24262CAS: 308242-62-8 | Min. 95% | - - - | Discontinued product |
Remimazolam
Controlled ProductCAS:308242-62-8
Applications Remimazolam, is a drug and benzodiazepine derivative. It is used as an alternative to …
Formula:
C21H19BrN4O2
Color and Shape:
Neat
Molecular weight:
439.31
Ref: TR-R143600
| 1mg | 244.00 € | ||
| 5mg | 1,027.00 € | ||
| 10mg | 1,658.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
Remimazolam
Controlled ProductCAS:308242-62-8
Please enquire for more information about Remimazolam including the price, delivery time and more detailed …
Formula:
C21H19BrN4O2
Purity:
Min. 95%
Molecular weight:
439.3 g/mol
Ref: 3D-FR181797
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 23 Dec 2024
Methyl 3-(8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo(1,2-A)(1,4)benzodiazepin-4-yl)propanoate
CAS:308242-62-8
Please enquire for more information about Methyl 3-(8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo(1,2-A)(1,4)benzodiazepin-4-yl)propanoate including the price, delivery time and more …
Formula:
C21H19BrN4O2
Purity:
Min. 95%
Molecular weight:
439.3 g/mol
Ref: 3D-IMA24262
| 1mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information |
